ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2,1,Pruritus genital,Reproductive tract signs and symptoms NEC,Reproductive tract disorders NEC,Repro,N
3,1,Pruritus genital,Reproductive tract signs and symptoms NEC,Reproductive tract disorders NEC,Repro,N
4,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
4,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
4,3,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
5,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
6,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
6,2,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
6,3,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
7,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
7,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
7,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
8,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
8,2,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
9,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
9,2,Local reaction,General signs and symptoms NEC,General system disorders NEC,Genrl,N
9,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
10,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
11,1,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
11,2,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
11,3,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
12,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
12,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
13,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
14,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
14,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
14,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
15,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
16,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
16,2,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
16,3,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
17,1,Rash vesicular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
18,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
19,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
19,2,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
20,1,Periorbital oedema,Ocular disorders NEC,Eye disorders NEC,Eye,N
21,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
22,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
22,2,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
22,3,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
23,1,Application site oedema,Application site reactions,Administration site reactions,Genrl,N
24,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
25,1,Dermatitis bullous,Bullous conditions,Epidermal and dermal conditions,Skin,N
25,2,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
26,1,Inflammation,Inflammations,General system disorders NEC,Genrl,N
27,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
28,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
29,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
29,2,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
30,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
30,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
30,3,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
31,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
32,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
33,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
34,1,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
35,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
36,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
37,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
38,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
39,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
40,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
40,2,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
41,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
42,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
42,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
43,1,Proctitis,Rectal inflammations NEC,Gastrointestinal inflammatory conditions,Gastr,N
44,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
45,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
46,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
47,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
48,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
49,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
50,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
50,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
51,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
52,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
52,2,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
52,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
53,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
54,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
55,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
55,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
55,3,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
55,4,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
55,5,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
56,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
57,1,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
58,1,Coma,Coma states,Neurological disorders NEC,Nerv,N
58,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
58,3,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
58,4,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
58,5,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
59,1,Local reaction,General signs and symptoms NEC,General system disorders NEC,Genrl,N
60,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
61,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
62,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
62,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
63,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
64,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
64,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
64,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
65,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
66,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
66,2,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
67,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
67,2,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
68,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
69,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
69,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
70,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
71,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
72,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
73,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
74,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
75,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
75,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
76,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
77,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
78,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
79,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
80,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
80,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
81,1,Local reaction,General signs and symptoms NEC,General system disorders NEC,Genrl,N
82,1,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
83,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
84,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
84,2,Local reaction,General signs and symptoms NEC,General system disorders NEC,Genrl,N
85,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
85,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
86,1,Face oedema,Oedema NEC,General system disorders NEC,Genrl,N
86,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
87,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
88,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
89,1,Petechiae,Purpura and related conditions,Skin vascular abnormalities,Skin,N
90,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
91,1,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
92,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
93,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
93,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
94,1,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
95,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
95,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
96,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
97,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
97,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
98,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
98,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
99,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
99,2,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
100,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
101,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
102,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
103,1,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
104,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
105,1,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
106,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
107,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
108,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
108,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
108,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
109,1,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
109,2,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
109,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
110,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
111,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
112,1,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
112,2,Skin hypertrophy,Skin hyperplasias and hypertrophies,Cornification and dystrophic skin disorders,Skin,N
113,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
113,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
114,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
114,2,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
115,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
116,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
117,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
117,2,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
118,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
119,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
120,1,Erythema induratum,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
120,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
121,1,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
122,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
123,1,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
124,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
124,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
125,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
126,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
127,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
127,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
128,1,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
128,2,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
129,1,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
130,1,Urticaria contact,Urticarias,Angioedema and urticaria,Skin,N
131,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
131,2,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
132,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
132,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
133,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
134,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
135,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
136,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
137,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
138,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
138,2,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
139,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
140,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
141,1,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
142,1,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
143,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
143,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
144,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
145,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
145,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
145,3,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
145,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
146,1,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
147,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
148,1,Conjunctivitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
148,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
149,1,Conjunctivitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
149,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
150,1,Rash vesicular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
151,1,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
152,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
153,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
154,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
155,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
156,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
156,2,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
156,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
157,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
158,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
159,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
160,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
161,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
162,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
163,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
164,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
164,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
164,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
165,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
166,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
166,2,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
166,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
167,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
167,2,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
168,1,Local reaction,General signs and symptoms NEC,General system disorders NEC,Genrl,N
169,1,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
170,1,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
170,2,Periorbital oedema,Ocular disorders NEC,Eye disorders NEC,Eye,N
170,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
171,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
171,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
172,1,Local reaction,General signs and symptoms NEC,General system disorders NEC,Genrl,N
173,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
174,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
175,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
175,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
175,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
176,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
177,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
178,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
179,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
180,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
181,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
182,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
183,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
184,1,Local reaction,General signs and symptoms NEC,General system disorders NEC,Genrl,N
185,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
186,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
186,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
187,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
188,1,Application site oedema,Application site reactions,Administration site reactions,Genrl,N
188,2,Inflammation,Inflammations,General system disorders NEC,Genrl,N
189,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
190,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
191,1,Local reaction,General signs and symptoms NEC,General system disorders NEC,Genrl,N
192,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
192,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
193,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
194,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
195,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
195,2,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
196,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
197,1,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
198,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
198,2,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
199,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
200,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
201,1,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
202,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
203,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
204,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
205,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
206,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
207,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
208,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
208,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
209,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
210,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
211,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
212,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
213,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
214,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
215,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
216,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
217,1,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
218,1,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
218,2,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
219,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
219,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
220,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
220,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
220,3,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
221,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
222,1,Local reaction,General signs and symptoms NEC,General system disorders NEC,Genrl,N
223,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
224,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
225,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
226,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
226,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
227,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
228,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
228,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
228,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
229,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
230,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
231,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
231,2,Skin hyperpigmentation,Hyperpigmentation disorders,Pigmentation disorders,Skin,N
232,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
232,2,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
232,3,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
233,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
234,1,Rash vesicular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
235,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
236,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
237,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
238,1,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
238,2,Type I hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
239,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
240,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
240,2,Laryngeal oedema,"Laryngeal spasm, oedema and obstruction",Upper respiratory tract disorders (excl infections),Resp,N
240,3,Stridor,"Laryngeal spasm, oedema and obstruction",Upper respiratory tract disorders (excl infections),Resp,N
241,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
242,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
242,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
243,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
244,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
245,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
245,2,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
246,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
247,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
248,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
249,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
250,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
251,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
252,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
253,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
254,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
255,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
256,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
257,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
258,1,Mydriasis,Pupil disorders,Ocular neuromuscular disorders,Eye,N
259,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
260,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
261,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
262,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
263,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
264,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
265,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
265,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
266,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
267,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
268,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
269,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
270,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
270,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
270,3,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
270,4,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
271,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
272,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
273,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
274,1,Skin test positive,Immunology skin tests NEC,Immunology and allergy investigations,Inv,N
275,1,Skin test positive,Immunology skin tests NEC,Immunology and allergy investigations,Inv,N
276,1,Skin test positive,Immunology skin tests NEC,Immunology and allergy investigations,Inv,N
277,1,Skin test positive,Immunology skin tests NEC,Immunology and allergy investigations,Inv,N
278,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
279,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
279,2,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
279,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
280,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
280,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
281,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
282,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
283,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
284,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
285,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
285,2,Mesenteric lymphadenitis,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
286,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
287,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
288,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
289,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
289,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
290,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
291,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
292,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
293,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
294,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
294,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
295,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
295,2,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
295,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
296,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
297,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
298,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
299,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
300,1,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
301,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
302,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
302,2,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
303,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
304,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
304,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
305,1,Inflammation,Inflammations,General system disorders NEC,Genrl,N
306,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
307,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
307,2,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
307,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
308,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
309,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
310,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
310,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
311,1,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
312,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
312,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
313,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
314,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
314,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
315,1,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
315,2,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
316,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
316,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
317,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
317,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
318,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
319,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
319,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
320,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
321,1,Application site oedema,Application site reactions,Administration site reactions,Genrl,N
321,2,Application site rash,Application site reactions,Administration site reactions,Genrl,N
321,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
322,1,Application site oedema,Application site reactions,Administration site reactions,Genrl,N
322,2,Application site rash,Application site reactions,Administration site reactions,Genrl,N
323,1,Application site oedema,Application site reactions,Administration site reactions,Genrl,N
323,2,Application site rash,Application site reactions,Administration site reactions,Genrl,N
323,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
324,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
325,1,Erythema induratum,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
326,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
327,1,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
328,1,Corneal disorder,Corneal disorders NEC,Eye disorders NEC,Eye,N
329,1,Corneal disorder,Corneal disorders NEC,Eye disorders NEC,Eye,N
330,1,Urticaria contact,Urticarias,Angioedema and urticaria,Skin,N
331,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
332,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
333,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
334,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
335,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
336,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
337,1,Local reaction,General signs and symptoms NEC,General system disorders NEC,Genrl,N
338,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
339,1,Local reaction,General signs and symptoms NEC,General system disorders NEC,Genrl,N
340,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
341,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
342,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
342,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
343,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
344,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
344,2,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
345,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
346,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
346,2,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
347,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
348,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
349,1,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
349,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
349,3,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
350,1,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
350,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
351,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
352,1,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
352,2,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
353,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
354,1,Application site inflammation,Application site reactions,Administration site reactions,Genrl,N
354,2,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
355,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
355,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
355,3,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
356,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
356,2,Local reaction,General signs and symptoms NEC,General system disorders NEC,Genrl,N
357,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
358,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
359,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
359,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
360,1,Skin test positive,Immunology skin tests NEC,Immunology and allergy investigations,Inv,N
361,1,Inflammation,Inflammations,General system disorders NEC,Genrl,N
361,2,Rash vesicular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
362,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
363,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
363,2,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
363,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
364,1,Skin test positive,Immunology skin tests NEC,Immunology and allergy investigations,Inv,N
365,1,Local reaction,General signs and symptoms NEC,General system disorders NEC,Genrl,N
366,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
367,1,Erythema induratum,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
368,1,Application site urticaria,Application site reactions,Administration site reactions,Genrl,N
368,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
369,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
370,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
371,1,Dermatitis bullous,Bullous conditions,Epidermal and dermal conditions,Skin,N
372,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
372,2,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
373,1,Corneal oedema,"Corneal infections, oedemas and inflammations","Ocular infections, irritations and inflammations",Eye,N
374,1,Corneal oedema,"Corneal infections, oedemas and inflammations","Ocular infections, irritations and inflammations",Eye,N
375,1,Corneal oedema,"Corneal infections, oedemas and inflammations","Ocular infections, irritations and inflammations",Eye,N
376,1,Corneal oedema,"Corneal infections, oedemas and inflammations","Ocular infections, irritations and inflammations",Eye,N
377,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
378,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
378,2,Application site oedema,Application site reactions,Administration site reactions,Genrl,N
378,3,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
379,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
379,2,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
380,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
381,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
381,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
381,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
382,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
382,2,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
383,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
383,2,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
384,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
384,2,Application site inflammation,Application site reactions,Administration site reactions,Genrl,N
384,3,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
385,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
385,2,Oral discomfort,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
385,3,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
386,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
386,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
386,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
387,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
387,2,Inflammation,Inflammations,General system disorders NEC,Genrl,N
388,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
388,2,Petechiae,Purpura and related conditions,Skin vascular abnormalities,Skin,N
388,3,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
389,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
389,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
390,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
390,2,Application site swelling,Application site reactions,Administration site reactions,Genrl,N
391,1,Endophthalmitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
391,2,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
392,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
393,1,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
394,1,Localised oedema,Oedema NEC,General system disorders NEC,Genrl,N
395,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
395,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
396,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
396,2,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
396,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
397,1,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
397,2,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
398,1,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
398,2,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
398,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
399,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
399,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
400,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
400,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
400,3,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
401,1,Burns second degree,Thermal burns,Injuries by physical agents,Inj&P,N
401,2,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
402,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
402,2,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
403,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
403,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
404,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
404,2,Application site oedema,Application site reactions,Administration site reactions,Genrl,N
404,3,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
404,4,Application site swelling,Application site reactions,Administration site reactions,Genrl,N
404,5,Application site vesicles,Application site reactions,Administration site reactions,Genrl,N
404,6,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
404,7,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
404,8,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
404,9,Vasodilatation,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
405,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
405,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
405,3,Headache,Headaches NEC,Headaches,Nerv,N
405,4,Hypoaesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
405,5,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
405,6,Type I hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
406,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
406,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
406,3,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
406,4,Type I hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
407,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
407,2,Skin oedema,Skin vascular conditions NEC,Skin vascular abnormalities,Skin,N
408,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
409,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
409,2,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
409,3,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
409,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
410,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
410,2,Application site swelling,Application site reactions,Administration site reactions,Genrl,N
410,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
411,1,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
411,2,Application site swelling,Application site reactions,Administration site reactions,Genrl,N
411,3,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
412,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
413,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
413,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
413,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
413,4,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
414,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
415,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
415,2,Skin haemorrhage,Skin haemorrhages,Skin vascular abnormalities,Skin,N
416,1,Application site vesicles,Application site reactions,Administration site reactions,Genrl,N
417,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
418,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
418,2,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
419,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
419,2,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
419,3,Heart rate decreased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
419,4,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
419,5,Sinus arrhythmia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
419,6,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
420,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
420,2,Chemical burns of eye,Chemical injuries,"Exposures, chemical injuries and poisoning",Inj&P,N
420,3,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
420,4,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
420,5,Language disorder,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
420,6,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
420,7,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
421,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
421,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
421,3,Sinus arrhythmia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
421,4,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
421,5,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
422,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
423,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
424,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
424,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
425,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
425,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
426,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
426,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
427,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
427,2,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
428,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
428,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
428,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
428,4,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
429,1,Application site hypoaesthesia,Application site reactions,Administration site reactions,Genrl,N
429,2,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
430,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
430,2,Application site vesicles,Application site reactions,Administration site reactions,Genrl,N
431,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
432,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
433,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
434,1,Application site bruise,Application site reactions,Administration site reactions,Genrl,N
434,2,Application site burn,Application site reactions,Administration site reactions,Genrl,N
434,3,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
434,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
434,5,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
435,1,Application site swelling,Application site reactions,Administration site reactions,Genrl,N
435,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
436,1,Mydriasis,Pupil disorders,Ocular neuromuscular disorders,Eye,N
437,1,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
437,2,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
438,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
439,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
440,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
440,2,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
441,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
441,2,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
441,3,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
442,1,Application site vesicles,Application site reactions,Administration site reactions,Genrl,N
443,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
444,1,Application site burn,Application site reactions,Administration site reactions,Genrl,N
444,2,Application site dryness,Application site reactions,Administration site reactions,Genrl,N
444,3,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
444,4,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
444,5,Application site scab,Application site reactions,Administration site reactions,Genrl,N
445,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
446,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
446,2,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
446,3,Application site swelling,Application site reactions,Administration site reactions,Genrl,N
447,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
448,1,Administration site urticaria,Administration site reactions NEC,Administration site reactions,Genrl,N
449,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
450,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
450,2,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
451,1,Application site burn,Application site reactions,Administration site reactions,Genrl,N
451,2,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
451,3,Application site vesicles,Application site reactions,Administration site reactions,Genrl,N
452,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
453,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
454,1,Application site burn,Application site reactions,Administration site reactions,Genrl,N
455,1,Application site inflammation,Application site reactions,Administration site reactions,Genrl,N
455,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
455,3,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
456,1,Chemical burn,Chemical injuries,"Exposures, chemical injuries and poisoning",Inj&P,N
457,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
457,2,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
458,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
459,1,Chemical burn of skin,Chemical injuries,"Exposures, chemical injuries and poisoning",Inj&P,N
459,2,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
460,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
460,2,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
461,1,Administration site swelling,Administration site reactions NEC,Administration site reactions,Genrl,N
461,2,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
461,3,Injection site inflammation,Injection site reactions,Administration site reactions,Genrl,N
462,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
463,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
463,2,Anger,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
463,3,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
463,4,Application site oedema,Application site reactions,Administration site reactions,Genrl,N
463,5,Catheter site pain,Implant and catheter site reactions,Administration site reactions,Genrl,N
463,6,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
463,7,Fear of injection,Fear symptoms and phobic disorders (incl social phobia),Anxiety disorders and symptoms,Psych,N
463,8,Phobia,Fear symptoms and phobic disorders (incl social phobia),Anxiety disorders and symptoms,Psych,N
464,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
464,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
464,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
464,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
465,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
465,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
466,1,Administration site erythema,Administration site reactions NEC,Administration site reactions,Genrl,N
467,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
468,1,Application site vesicles,Application site reactions,Administration site reactions,Genrl,N
468,2,Application site vesicles,Application site reactions,Administration site reactions,Genrl,N
469,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
470,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
471,1,Administration site erythema,Administration site reactions NEC,Administration site reactions,Genrl,N
472,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
472,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
472,3,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
473,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
473,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
473,3,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
474,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
474,2,Papule,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
475,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
476,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
476,2,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
476,3,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
477,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
477,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
478,1,Application site burn,Application site reactions,Administration site reactions,Genrl,N
478,2,Application site swelling,Application site reactions,Administration site reactions,Genrl,N
478,3,Application site warmth,Application site reactions,Administration site reactions,Genrl,N
478,4,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
478,5,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
478,6,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
479,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
479,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
480,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
480,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
480,3,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
481,1,Thermal burns of eye,Thermal burns,Injuries by physical agents,Inj&P,N
482,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
482,2,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
483,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
484,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
484,2,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
485,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
486,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
